Update on external beam radiation therapy in thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 8, 2011, Pages 2289-2295

  Brierley, James D ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; PACLITAXEL; PAZOPANIB; SORAFENIB; TAXANE DERIVATIVE;

ACCURACY; ANAPLASTIC CARCINOMA; DIFFERENTIATED THYROID CANCER; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RADIOGRAPHY; REVIEW; THYROID CANCER; THYROID MEDULLARY CARCINOMA; TREATMENT RESPONSE;

CARCINOMA; CARCINOMA, MEDULLARY; HUMANS; RADIOTHERAPY; THYROID NEOPLASMS;

EID: 79961214920     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1109     Document Type: Review

References (25)

1. Tennvall J, Lundell G, Wahlberg P, Bergenfelz A, Grimelius L, Akerman M, Hjelm Skog AL, Wallin G 2002 Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 86:1848-1853
2. Wong CS, Van Dyk J, Simpson WJ 1991 Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol 20:3-9
3. Wang Y, Tsang R, Asa S, Dickson B, Arenovich T, Brierley J 2006 Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens. Cancer 107:1786-1792 (Pubitemid 44582947)
4. Dandekar P, Harmer C, Barbachano Y, Rhys-Evans P, Harrington K, Nutting C, Newbold K 2009 Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysis. Int J Radiat Oncol Biol Phys 74:518-521
5. Ain KB, Egorin MJ, DeSimone PA 2000 Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 10:587-594 (Pubitemid 30670619)
6. Bhatia A, Rao A, Ang KK, Garden AS, Morrison WH, Rosenthal DI, Evans DB, Clayman G, Sherman SI, Schwartz DL 2010 Anaplastic thyroid cancer: clinical outcomes with conformal radiotherapy. Head Neck 32:829-836
7. Troch M, Koperek O, Scheuba C, Dieckmann K, Hoffmann M, Niederle B, Raderer M 2010 High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel. J Clin Endocrinol Metab 95:E54-E57
8. Foote RL, Molina JR, Kasperbauer JL, Lloyd RV, McIver B, Morris JC, Grant CS, Thompson GB, Richards ML, Hay ID, Smallridge RC, Bible KC 2011 Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy. Thyroid 21:25-30
9. Sherman SI 2011 Targeted therapies for thyroid tumors. Mod Pathol 24(Suppl 2):S44-S52
10. Ha HT, Lee JS, Urba S, Koenig RJ, Sisson J, Giordano T, Worden FP 2010 A phase II study of imatinib in patients with advanced anaplastic thyroid cancer. Thyroid 20:975-980
11. Hogan T, Jing Jie Yu, Williams HJ, Altaha R, Xiaobing Liang, Qi He 2009 Oncocytic, focally anaplastic, thyroid cancer responding to erlotinib. J Oncol Pharm Pract 15:111-117
12. Chi KH, Lias CS, Chang CC, Ko HL, Tsang YW, Yang KC, Mehta MP 2010 Angiogenic blockade and radiotherapy in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 78:188-193
13. Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Vini L, Harmer C, Dearnaley DP, Webb S 2001 Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 60:173-180 (Pubitemid 32605696)
14. Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, Evans DB, Clayman G, Sherman SI, Garden AS 2009 Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Int J Radiat Oncol Biol Phys 74:1083-1091
15. British Thyroid Association 2006 Guidelines for the management of thyroid cancer in adults. London: Royal College of Physicians; 1-70
16. Biermann M, Pixberg M, Riemann B, Schuck A, Heinecke A, Schmid KW, Willich N, Dralle H, Schober O; MSDS Study Group 2009 Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer-results after 874 patient-years of follow-up in the MSDS-trial. Nuklearmedizin 48:89-98; quiz N15
17. Terezakis SA, Lee KS, Ghossein RA, Rivera M, Tuttle RM, Wolden SL, Zelefsky MJ, Wong RJ, Patel SG, Pfister DG, Shaha AR, Lee NY 2009 Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 73:795-801
18. Azrif M, Slevin NJ, Sykes AJ, Swindell R, Yap BK 2008 Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Radiother Oncol 89:105-113
19. Sia MA, Tsang RW, Panzarella T, Brierley JD 2010 Differentiated thyroid cancer with extrathyroidal extension: prognosis and the role of external beam radiotherapy. J Thyroid Res 2010:183461
20. Kim TH, Chung KW, Lee YJ, Park CS, Lee EK, Kim TS, Kim SK, Jung YS, Ryu JS, Kim SS, Cho KH, Shin KH 2010 The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer. Radiat Oncol 5:69
21. Martinez SR, Beal SH, Chen A, Chen SL, Schneider PD 2010 Adjuvant external beam radiation for medullary thyroid carcinoma. J Surg Oncol 102:175-178
22. Brierley J, Tsang R, Simpson WJ, Gospodarowicz M, Sutcliffe S, Panzarella T 1996 Medullary thyroid cancer - analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6:305-310 (Pubitemid 26303135)
23. Fife KM, Bower M, Harmer CL 1996 Medullary thyroid cancer: the role of radiotherapy in local control. Eur J Surg Oncol 22:588-591 (Pubitemid 27036198)
24. Schwartz DL, Rana V, Shaw S, Yazbeck C, Ang KK, Morrison WH, Rosenthal DI, Hoff A, Evans DB, Clayman GL, Garden AS, Sherman SI 2008 Postoperative radiotherapy for advanced medullary thyroid cancer - local disease control in the modern era. Head Neck 30:883-888 (Pubitemid 352008948)
25. Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214